Table 2:

Values of cerebral blood flow (CBF), cerebral blood volume (CBV), mean transit time (MTT), and mean diffusivity 〈D〉 for the entire volume of nonenhancing peritumoral edematous brain pre- and postdexamethasone treatment for the 7 patients who had regions of edema on T2-weighted EPI

Patient No.Peritumoral Edematous Brain
CBF (mL/100 g/min)CBV (mL/100 g)MTT (s)<D> (×10−6 mm2/s)
PresteroidsPoststeroidsPresteroidsPoststeroidsPresteroidsPoststeroidsPresteroidsPoststeroids
116.3 ± 6.718.1 ± 7.71.5 ± 0.71.0 ± 0.43.7 ± 1.12.3 ± 0.61465 ± 2311401 ± 196
319.8 ± 11.724.1 ± 13.91.9 ± 1.42.0 ± 1.43.7 ± 1.13.2 ± 0.91484 ± 2751407 ± 262
420.8 ± 7.222.3 ± 7.91.6 ± 0.61.7 ± 0.63.1 ± 0.73.1 ± 0.51153 ± 1671081 ± 146
619.8 ± 11.624.4 ± 15.31.4 ± 1.02.3 ± 1.52.9 ± 0.84.2 ± 2.91537 ± 2371418 ± 232
720.7 ± 15.824.2 ± 19.11.8 ± 1.41.8 ± 1.43.7 ± 1.63.0 ± 0.81578 ± 2681466 ± 262
817.1 ± 5.114.6 ± 3.51.2 ± 0.41.0 ± 0.33.6 ± 1.32.6 ± 0.31627 ± 1061542 ± 136
914.4 ± 9.516.7 ± 9.41.3 ± 0.91.7 ± 1.03.7 ± 0.64.2 ± 1.31290 ± 1931209 ± 197
Mean18.4 ± 2.520.6 ± 4.11.5 ± 0.31.6 ± 0.53.4 ± 0.43.2 ± 0.71448 ± 1691361 ± 159
ε (%); P11.6 ± 12.8; .057.2 ± 30.5; .53−2.8 ± 25.8; .67−6.0 ± 1.2; <.001
  • All values are reported as mean (±SD). The mean volume of edematous brain was 62.4 ± 52.7 × 103 mm3.